News Hub | News Direct

All Industries


Article thumbnail News Release

Republic Set to List First-of-its-Kind Profit-Sharing Digital Security, the Republic Note

Republic

Republic has announced it is set to list its profit-sharing digital asset, the Republic Note, on INX’s US-regulated trading platform via the Avalanche blockchain. The listing, which marks a transformative step toward making private market investments more accessible to and tradable among investors around the world, is scheduled to occur on December 6, 2023. While investing in most private companies is inaccessible to the general public and requires accreditation and large check sizes, the Republic Note is available to non-accredited investors globally at low minimums. The Note distributes dividends to holders’ digital wallets as new liquidity events occur in the Republic portfolio. In a digital asset market overflowing with tokens, the Republic Note offers diversification into a high-growth, highly vetted venture-quality portfolio. Since Republic’s 2016 inception, its community of 3+ million members across 150+ countries have deployed $2.6+ billion into privately held ventures. The Republic Note is a real-world asset-backed digital security that unlocks access to the financial upside of Republic’s expansive venture portfolio of 750+ private companies and assets, including SpaceX, Dapper Labs, Carta, and more. * These deals are hosted by Republic Capital, an SEC registered investment adviser. View its full portfolio here. Kendrick Nguyen, Republic’s Co-founder and CEO, emphasized the importance of the event: “The Republic Note’s listing is not just a milestone for Republic—it represents a shift in the landscape of private equity. We believe this is the first time a digital asset backed by such a diverse portfolio of private ventures has been made available to retail investors. Owning even one Republic Note can unlock an important new level of accessibility, transparency, and liquidity to private equity.” The path to the Republic Note’s public listing has been characterized by overwhelming interest, with over $30 million in pre-sale participation from organizations like Naspers, Binance, and the Avalanche Foundation's Vista program, as well as thousands of individual investors. On Republic’s journey to list its digital security, it too has garnered support from strong institutional backers, raising over $200 million from global firms like Valor Equity Partners, Galaxy Interactive, Morgan Stanley, and AngelList. Recently, the firm announced that the Republic Note would launch on Avalanche to leverage the blockchain’s scale, speed, and customizability. Republic, INX, and Ava Labs (a software provider for the Avalanche network) are leading pioneers in tokenization, a market on a trajectory to grow into the tens of trillions of dollars this decade. In addition to expanding access, tokenization can create greater efficiencies that improve both the asset issuer and investor experience. Republic is leveraging a long track record navigating a dynamic regulatory environment, especially for digital assets. Founded in the wake of the JOBS Act by Nguyen, then AngelList’s General Counsel, Republic became one of the first platforms to enable private companies to raise capital from nonaccredited investors through Regulation CF. Now, combining nearly a decade of financial engineering, blockchain-based asset management strategy, investment infrastructure, and securities licenses, the Republic Note is poised to deliver on Republic’s mission to democratize private markets globally. Republic has chosen INX.One, INX’s global trading platform, as the hub for the Republic Note listing. INX’s CEO Shy Datika shared: “We are proud to list the Republic Note on INX.One, the first and only fully regulated trading platform for both security tokens and cryptocurrencies. Listing the Republic Note helps our vision to democratize finance come full circle—providing investors with the only secure way to trade and invest under the US regulatory umbrella.” For more details on the Republic Note and its December 6 listing on INX.One, visit republic.com/note. About Republic Republic is a global technology firm pioneering the digital transformation of finance. The Republic ecosystem is composed of an enterprise-focused Digital Merchant Bank and a retail-focused Global Marketplace. Republic has made it possible for 3+ million community members across 150+ countries to deploy $2.6+ billion into thousands of private ventures. Backed by Valor Equity Partners, Galaxy Interactive, Morgan Stanley, Hashed, AngelList, and other leading institutions, Republic is headquartered in New York City and has established operations in the US, UK, EU, UAE, and South Korea. Republic: Website | Twitter | LinkedIn // Republic Note: Website | Twitter Contact Details Dan Edelstein pr@marketacross.com

November 29, 2023 12:30 PM Eastern Standard Time

Image
Article thumbnail News Release

Aruma Resources uncovers new gold target at Saltwater

Aruma Resources Ltd

Aruma Resources Ltd (ASX:AAJ) MD Glenn Grayson tells Proactive an ongoing soil sampling program at the company’s 100%-owned Saltwater Project in the Pilbara region of Western Australia has uncovered a “very anomalous” greenfield gold target at the Terceira prospect. In addition, the program has confirmed the existence of volcanogenic massive sulphide (VMS) systems with elements such as manganese, barium, copper and cobalt at the Orichalcum prospect, and a series of rare earth elements (REE) and telluride anomalies at the Oracle prospect. “The results from our ongoing sampling program are very encouraging and highlight the project’s potential by continuing to deliver materially positive results from this initial, targeted fieldwork," Grayson said. “Based on results to date, we are confident we have identified a high-value manganese-cobalt target, multiple VMS targets, as well as a promising uranium prospect – and with the latest phase of sampling, have uncovered an exciting, new greenfield gold target." Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 Jonathan@proactiveinvestors.com

November 29, 2023 12:15 PM Eastern Standard Time

Video
Article thumbnail News Release

Africa CDC and Mastercard Foundation launch phase 2 of the Saving Lives and Livelihoods (SLL) initiative to strengthen Africa’s public health systems

Mastercard Foundation

LUSAKA, ZAMBIA - African Media Agency - 29 November 2023 - The Africa CDC and the Mastercard Foundation have entered a new phase of their partnership on the Saving Lives and Livelihoods initiative in the aftermath of WHO's declaration of the end of COVID-19 pandemic as a public health emergency of international concern. The Saving Lives and Livelihoods initiative, a bold and unprecedented $1.5 billion partnership, was launched in June 2021. This innovative and ground-breaking partnership aimed to purchase COVID-19 vaccines, roll out vaccinations, build the vaccine manufacturing workforce for the continent, and strengthen the Africa CDC to ensure long-term health security for Africa. Unprecedented in scale, speed and inclusion of African organisations, the partnership has contributed to the continent's current vaccination rate of 53 per cent of the target population, up from just 3 per cent at the start of the initiative. The partnership has also trained, equipped, and deployed 38,000 health workers, creating a robust frontline in safeguarding public health locally. It has provided job opportunities for 23,000 individuals and integrated over 600 COVID-19 vaccination centres into healthcare systems. Additionally, this initiative led to the expansion of genomic testing capabilities from seven to 40 laboratories across the continent. The review of Phase 1 of this initiative, among fifteen implementing partners across 29 countries, conducted by Deloitte, indicates that the vast majority of funds disbursed were used effectively and as intended. Likewise, ongoing monitoring by KPMG has confirmed that partners not only showed strength in programmatic results but also improved the institutional capacity for greater sustainability and institutional resilience. "Our Saving Lives and Livelihoods initiative with the Mastercard Foundation has shown the power of respectful and action-oriented partnerships rooted in collaboration, coordination and systems strengthening. The experience and learnings from Phase I will enable us to move with greater speed and scale to deliver with accelerated impact to our member states" said Dr. Jean Kaseya, Director General of the Africa CDC. In its second phase, the partnership will expand its scope and scale, focusing on completing the vaccination of healthcare workers and vulnerable groups, building a robust workforce of community health workers, ensuring pandemic preparedness by bolstering national public health institutions, laboratory capacities, data access and quality, local manufacturing of vaccines, therapeutics and diagnostics, and continuing strengthening of Africa CDC. "While the global pandemic may be declared over, the need to continue investing in our health systems, build our workforce and prepare for future pandemics remains urgent. This partnership will ensure that we have strong health institutions and systems. We aim to enable thousands of young people to build their careers in healthcare and contribute to improving lives in Africa," said Reeta Roy, President, and CEO of the Mastercard Foundation. The Saving Lives and Livelihoods initiative stands out as a testament to the power of African-led health solutions. As it progresses to its next phase, partnerships will continue to play a crucial role in shaping a New Public Health Order for Africa. Africa CDC and the Mastercard Foundation remain committed to improving the health and well-being of all Africans. About the Africa Centres for Disease Control and Prevention (Africa CDC) Africa CDC is a continental autonomous health agency of the African Union established to support public health initiatives of Member States and strengthen the capacity of their public health institutions to detect, prevent, control, and respond quickly and effectively to disease threats. For more information, please visit: http://www.africacdc.org About the Mastercard Foundation The Mastercard Foundation is a registered Canadian charity and one of the largest foundations in the world. It works with visionary organisations to advance education and financial inclusion, enabling young people in Africa and Indigenous youth in Canada to access dignified and fulfilling work. Established in 2006 through the generosity of Mastercard when it became a public company, the Foundation is an independent organisation separate from the company, with offices in Toronto, Kigali, Accra, Nairobi, Kampala, Lagos, Dakar, and Addis Ababa. Its policies, operations, and program decisions are determined by the Foundation's Board of Directors and leadership. For more information on the Foundation, please visit www.mastercardfdn.org. Contact Details Wariko Kabuga-Waita wwaita@mastercardfdn.org

November 29, 2023 12:13 PM Eastern Standard Time

Image
Article thumbnail News Release

TSA Records Busiest Air Travel Day in US History

MarketJar

Airlines just survived their busiest travel season in US history, with the Transportation Security Administration (TSA) reporting a record-high screening of 2.9 million passengers on Sunday alone. 1 American Airlines announced an all-time high of approximately 6.5 million passengers during the Thanksgiving period, and its busiest day on Sunday, with over 6,100 flights. United Airlines also saw a record-breaking number of travelers, with 3.2 million flying between November 17 and November 23, leading up to Thanksgiving. The record travel day happened in spite of a cross-country storm that delayed over 900 flights at the busy Chicago O'Hare International Airport. In total, there were 7,939 delays within, into, or out of the US on Sunday. 2 Fortunately, only 55 flights were canceled, three of which were out of O’Hare. This busy travel day could become the new norm as passengers return to the skies en masse. “In 2023, we have already seen seven of the top 10 busiest travel days in TSA’s history,” said TSA Administrator David Pekoske. 3 Pekoske said the TSA would be collaborating closely with airline and airport partners leading up to the holiday season, with a goal to maintain wait time standards of under 10 minutes for TSA PreCheck® lanes and under 30 minutes for standard screening lanes. Last week, US Transportation Secretary Pete Buttigieg mentioned efforts to enhance readiness for heightened holiday travel, including the recruitment of additional air traffic controllers and the establishment of new air routes along the East Coast. Travel last year rebounded to 2019 levels, but it was marred by weather and staffing challenges, resulting in dissatisfaction and stranded travelers during the holidays. This year, even more travelers means inevitably longer lineups at security checkpoints and longer wait times at major hubs, a problem that has been getting consistently worse as travel returns to pre-pandemic highs. Fortunately, AI security tech company Liberty Defense Holdings (TSXV:SCAN) (OTCQB:LDDFF) has started implementing its HEXWAVE™ system in airports across North America to greatly improve security screening for both passengers and staff. A Fast, Contactless Screening Liberty Defense ’s HEXWAVE™ system uses a combination of AI, electromagnetic waves, and 3D imaging to effectively scan and identify potentially hazardous items, such as metal, 3D-printed plastic guns, powders, and liquids. The process is remarkably swift, requiring employees to pass through a contactless walkthrough portal without having to remove their keys or cell phones. Liberty Defense has also recently acquired licenses for millimeter wave-based High-Definition Advanced Imaging Technology (HD-AIT) body scanners and shoe scanner technologies, expanding its technology portfolio. Liberty Defense has successfully delivered a HEXWAVE™ system to the Transportation Security Administration (TSA), marking the completion of the contract under the TSA’s On-Person Screening Capability Program for screening Aviation Workers. "Over the past several months, we have been working closely with major US airports, including LAX, Denver, Oakland, and others on enhancing employee screening to reduce the potential of an insider threat,” said Bill Frain, Liberty CEO. “The focus of the program is to improve the detection for a broader range of threats while also improving the throughput for a practical and efficient process. A significant number of airports will be required to improve their screening process over the next several months. We look forward to supporting the initiative and making it a seamless transition.” Given the TSA's directive to implement screening measures for aviation workers, airports need technologies that offer a comprehensive range of threat detection capabilities to meet current screening requirements and those anticipated in the future. Liberty Defense ’s superior security detection solutions are thus of great help in this matter. On November XX, Liberty Defense Holdings (TSXV:SCAN) (OTCQB:LDDFF) became a recipient of the 2023 ‘ASTORS’ Homeland Security Award from American Security Today (AST) for its HEXWAVE™ solution. The 'ASTORS' Homeland Security Awards Program honors outstanding government and vendor solutions that offer significant value and intelligence in government, homeland security, and public safety sectors. Click here for more information about Liberty Defense (TSXV:SCAN) (OTCQB:LDDFF). [1] https://abcnews.go.com/US/thanksgiving-travel-tsa-breaks-record-highest-number-daily/story?id=105178080 [2] https://www.flightaware.com/live/cancelled/yesterday [3] https://www.tsa.gov/news/press/releases/2023/11/13/tsa-prepared-more-travelers-airport-security-checkpoints-expects Disclaimer 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Liberty Defense Holdings Ltd. Market Jar Media Inc. has or expects to receive from Liberty Defense Holdings Ltd.’s Digital Marketing Agency of Record (Native Ads Inc.) ninety five thousand USD for 36 days (26 business days). 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on pressreach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on pressreach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding Liberty Defense Holdings Ltd.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Liberty Defense Holdings Ltd.’s industry; (b) market opportunity; (c) Liberty Defense Holdings Ltd.’s business plans and strategies; (d) services that Liberty Defense Holdings Ltd. intends to offer; (e) Liberty Defense Holdings Ltd.’s milestone projections and targets; (f) Liberty Defense Holdings Ltd.’s expectations regarding receipt of approval for regulatory applications; (g) Liberty Defense Holdings Ltd.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Liberty Defense Holdings Ltd.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Liberty Defense Holdings Ltd.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Liberty Defense Holdings Ltd.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Liberty Defense Holdings Ltd.’s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) Liberty Defense Holdings Ltd.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Liberty Defense Holdings Ltd. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Liberty Defense Holdings Ltd.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Liberty Defense Holdings Ltd.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Liberty Defense Holdings Ltd.’s business operations (e) Liberty Defense Holdings Ltd. may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, Liberty Defense Holdings Ltd. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Liberty Defense Holdings Ltd. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Liberty Defense Holdings Ltd. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Liberty Defense Holdings Ltd. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Liberty Defense Holdings Ltd. or such entities and are not necessarily indicative of future performance of Liberty Defense Holdings Ltd. or such entities. 8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

November 29, 2023 11:55 AM Eastern Standard Time

Image
Article thumbnail News Release

Venture Minerals welcomes ‘phenomenal’ REE results at Jupiter

Venture Minerals Ltd

Venture Minerals Ltd (ASX:VMS) MD Andrew Radonjic tells Proactive the company has received outstanding assay results - including over 7,000 ppm TREO - from the maiden reverse circulation drilling program at the new Jupiter REE target. He says a resource definition drill program has commenced targeting around 5,000 metres and this is expected to take around three weeks. He adds that the scale and quality of this opportunity along with its proximity to infrastructure and processing plants makes it a standout among its peers. “These phenomenal results enhance Venture’s belief that the Jupiter target has the potential to become an exceptional rare earths project," Radonjic said. “The scale and quality of this opportunity along with its proximity to infrastructure and processing plants makes it a standout among its peers. There is road, power and port infrastructure adjacent to the Project. It is situated between Lynas’ existing plant and Iluka’s planned rare earth processing facilities.” Contact Details Proactive Investors Jonathan Jackson +61 413 713 744 Jonathan@proactiveinvestors.com

November 29, 2023 11:45 AM Eastern Standard Time

Video
Article thumbnail News Release

Alarming Surge: US Records Over 600 Mass Shootings in 2023

MarketJar

Just when you thought the gun violence in the US couldn’t get any worse, the nation is on track to hit a new record in mass shootings. So far in 2023, America has witnessed 618 mass shootings, signaling a troubling trend. 1 The data suggests a pace toward 700 mass shootings for the year, raising concerns about the ongoing surge in both shootings and fatalities. Tragically, the number of deaths resulting from gun violence remains at multi-year highs. In 2023 alone, more than 17,000 lives have been lost, compared to 20,200 in 2022, 21,009 in 2021, and 19,558 in 2020. Just a few weeks ago, the US witnessed its deadliest mass shooting of the year. On October 25, a devastating incident in Lewiston, Maine, claimed the lives of 18 people, with 13 others sustaining injuries. The perpetrator, identified as 40-year-old Army Reservist Robert Card, was found dead from a self-inflicted gunshot wound after a two-day manhunt by law enforcement. In response to the escalation in mass shootings, cities across the US are taking comprehensive measures to address gun violence and enhance public safety. While metal detectors are becoming a new norm in public places and school premises, the advent of ghost guns is making such preventative measures less effective. Meanwhile, advanced public safety technology company Knightscope, Inc. (NASDAQ:KSCP) is looking to help combat rising gun violence with a hyper-targeted approach. The Solution: Automated Gunshot Detection Knightscope, a leading developer of autonomous security robots (ASRs) and blue light emergency communication systems, just commenced sales of its real-time, automated gunshot detection (AGD) systems for both indoor and outdoor use. The system offers flexible installation options, including optional solar power or light pole kits and can be added to new or existing K1 Blue Light Towers. Knightscope 's decision to introduce this solution responds directly to requests from schools, corporations, airports, hotels, and municipalities considering the adoption of gunshot detection systems as part of their active threat and emergency response strategies. The AGD system is notable for its precision in locating gunshots, identifying both the horizontal and vertical positions. This feature is critical in rapidly directing police and security response to active shooter incidents, potentially saving lives and improving emergency response efficiency. Knightscope ’s initiative reflects a growing trend in security technology – focusing on rapid, accurate detection to improve public safety outcomes. Beyond just detection, Knightscope' s AGD system aims to reduce the prevalence of false alarms and work in tandem with other security measures. Upon detecting a gunshot, it sends notifications within two seconds, assuming adequate cellular connectivity. This approach by Knightscope represents a shift towards more localized, immediate response strategies in contrast to wider, city-wide systems, emphasizing the need for targeted and effective security solutions in contemporary public spaces. The company advocates for this on-site, focused approach as more effective than broader, city-wide systems. This innovation reflects Knightscope' s commitment to enhancing security measures in places where people live, work, study, and visit. For those interested in learning more about Knightscope's innovations and ongoing projects, additional information can be found by visiting the website of Knightscope, Inc. (NASDAQ:KSCP). Footnotes: [1] https://www.gunviolencearchive.org/ Disclosure: 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Knightscope, Inc. Market Jar Media Inc. has or expects to receive from Knightscope, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) two hundred and sixty-six thousand USD for 89 days (63 business days). 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management’s expectations regarding Knightscope, Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Knightscope, Inc.’s industry; (b) market opportunity; (c) Knightscope, Inc.’s business plans and strategies; (d) services that Knightscope, Inc. intends to offer; (e) Knightscope, Inc.’s milestone projections and targets; (f) Knightscope, Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Knightscope, Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Knightscope, Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Knightscope, Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Knightscope, Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Knightscope, Inc.’s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) Knightscope, Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Knightscope, Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Knightscope, Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Knightscope, Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Knightscope, Inc.’s business operations (e) Knightscope, Inc. may be unable to implement its growth strategy; and (f) increased competition.Except as required by law, Knightscope, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Knightscope, Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Knightscope, Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Knightscope, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Knightscope, Inc. or such entities and are not necessarily indicative of future performance of Knightscope, Inc. or such entities. 8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

November 29, 2023 10:40 AM Eastern Standard Time

Video Image
Article thumbnail News Release

FRX Completes Third Standstill Agreement with Key Strategic Supply Partner

FRX Innovations Inc

Boston, MA – TheNewswire - November 29, 2023 – FRX Innovations, Inc. (TSXV:FRXI) (FSE:W2A) (OTC:FRXI) (“FRX” or the “Company”), a pioneer in eco-friendly flame-retardant solutions, is pleased to announce the successful execution of a third standstill agreement with one of its key supplier partners, creating an important catalyst in support of the Company's ongoing strategic options process.   This agreement, which was executed on Nov 27, 2023, establishes the terms for the resolution of current trade arrangements between the two companies and more specifically provides favorable payment terms to FRX, meaningfully enhancing the Company's ability to proceed, unfettered, in its strategic journey.   The agreement specifies mutually agreed structured payments, by FRX, and assigns a priority of payments in the event of a potential transaction supported by the company’s shareholders and Board of Directors.     "FRX is committed to all its stakeholders and will continue its supply arrangements, ensuring the uninterrupted delivery of key products vital to FRX's operations.” Said Marc Lebel, CEO of FRX.  “Finalizing this standstill agreement paves the way for us to explore and execute our strategic options, ensuring the best possible outcomes for our shareholders, creditors, partners, customers and employees."   FRX remains steadfast in its strategic options process, with the goal of maximizing shareholder value and positioning the company for long-term success. Further updates on the strategic options process will be provided as they become available.   For more information about FRX and its strategic initiatives, please visit www.frx-innovations.com.   Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.   About FRX Innovations (www.frx-innovations.com) FRX Innovations is a global manufacturing company, producing a family of sustainable flame retardant products that serve several large markets spanning textiles, electronics, automotive, electric vehicles (EV), and medical devices. FRX is led by a team of highly experienced business and technical professionals and is positioned to be a leader in the rapidly changing flame-retardant plastics and additives market in response to new legislation prohibiting Brominated and Perfluoro flame retardants found in a wide range of electronics and electrical products and restricting the use of melamine flame retardant chemicals found in furniture and mattress foam products.   NOFIA® is a registered trademark of FRX. NOFIA® products are manufactured at its manufacturing facility on the Port of Antwerp in Belgium, one of the world's largest chemical producing clusters. NOFIA Polyphosphonates are produced using sustainable green chemistry principles such as a solvent-free production process, no waste by-products, and near 100% atom efficiency, and are halogen, PFAS and melamine free. FRX's portfolio includes an extensive patent estate. FRX has been at the forefront of the ESG movement to a greener future. The company has been the recipient of numerous awards, including the EPA's Environmental Merit Award, the Belgium Business Award for the Environment, and the Flanders Investment of the Year Award. FRX has also been recognized six times on the Global Cleantech 100 list.   Cautionary Note Regarding Forward-Looking Statements and Reader Advisory Certain statements contained in this news release, including, but not limited to, statements with respect to the Offering, the completion of the Offering, the size, amount and type of securities issued under the Offering, participation in the Offering by related parties and the amount of such participation, among other things, and statements which may contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, or similar expressions, and statements related to matters which are not historical facts, may constitute forward-looking information within the meaning of applicable securities laws. Such forward-looking statements, which reflect management’s expectations regarding the Company’s future growth, results of operations, performance, business prospects and opportunities, are based on certain factors and assumptions and involve known and unknown risks and uncertainties which may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking statements.   These factors should be considered carefully, and readers should not place undue reliance on the Company’s forward- looking statements. The Company believes that the expectations reflected in the forward-looking statements contained in this news release and the documents incorporated by reference herein are reasonable based on information available to it, but no assurance can be given that these expectations will prove to be correct.   Contact Information:     FRX Innovations  Mark Lotz   CFO     +1 604-880-6546 mlotz@frxpolymers.com Mike Goode CCO +1 765-838-9018 mgoode@frxpolymers.com FRX Innovations Investor Relations and Media Inquiries Investor Relations  Carl Desjardins +1 514-818-0447  Jean-Francois Meilleur +1 514-951-2730   Erik Danielson +41 76 335 4402       Diane Wilson   +1 978-505-1275     ir@frx-innovations.com Media Inquiries        Joseph Grande     +1 413-684-2463 joe@jgrandecommunications.com   #PFAS, #PFASfree, #ForeverChemical, #SustainableFR #ESG

November 29, 2023 10:20 AM Eastern Standard Time

Image
Article thumbnail News Release

Cuartos de final LIGA MX: fechas, horarios y donde apostar en los partidos de liguilla

Acroud Media

Los cuartos de final del Clausura 2023 de la Liga MX marcarán el emocionante inicio de la fase final de la competencia donde 8 destacados equipos competirán arduamente por el codiciado campeonato. A medida que el torneo está en su etapa final, la intensidad aumenta con la llegada de los cuartos de final. Los ocho equipos que avanzaron, basándose en sus posiciones de clasificación, ahora se enfrentarán en una lucha feroz por el título. Mientras tanto, los equipos ubicados del quinto al duodécimo lugar se embarcaron en la ronda de recalificación en busca de una oportunidad adicional. ¡No te pierdas ni un segundo de la acción! ¿Cuáles son los partidos de cuartos de final de la Liga MX? Con 40 puntos, el América lidera la competición y se enfrentará al León en las semifinales, mientras que el Atlético San Luis se medirá al Monterrey. El sorprendente Puebla, dirigido por Eduardo Arce, se enfrentará a Tigres en las semifinales, y los cuartos de final también incluirán el emocionante enfrentamiento entre Pumas y Chivas de Guadalajara. Entre los partidos de cuartos de final de la Liga MX son los siguientes: América - León Monterrey - Atlético San Luis Tigres - Puebla Pumas - Chivas Fechas y horarios de los partidos de ida en cuartos de final de la Liga MX 2023 Aquí tienes un resumen del calendario de los partidos de ida de cuartos de final: Equipos a enfrentarse de ida América vs León: Estadio Nou Camp, hora de juego 29 de noviembre 2023 a las 19:06 Monterrey vs Atlético San Luis: Estadio Alfonso Lastras, 29 de noviembre 2023 a las 21:10 Tigres vs Puebla: Estadio Cuauhtémoc, 30 de noviembre 2023 a las 19:00. Pumas vs Chivas: Estado Akron, 30 de noviembre 2023 a las 21:05 Fechas y horarios de los partidos de vuelta en cuartos de final de la Liga MX 2023 A continuación un detalle de los partidos de vuelta que se jugarán en los cuartos de final de la Liga MX 2023: Equipos a enfrentarse de vuelta América vs León: Estadio Azteca, 02 de diciembre de 2023 a las 19:00 Monterrey vs Atlético San Luis: Estadio BBVA, 02 de diciembre de 2023 a las 21:10 Tigres vs Puebla: Estadio Universitario, 02 de diciembre de 2023 a las 20:20 Pumas vs Chivas: Estadio Olímpico Universitario, 03 de diciembre de 2023 a las 18:00 ¿Dónde puedo ver los partidos de ida y vuelta de los cuartos de final del Apertura 2023? Primero que nada, asegúrate de sintonizar tus canales favoritos o utilizar los servicios de streaming correspondientes para no perderte ninguna acción de estos emocionantes encuentros. A continuación te dejamos la información sobre dónde podrás ver los emocionantes partidos de los cuartos de final de la Liga MX: Puebla vs Tigres: México, por medio del Canal 7 de TV Azteca, TUDN, Univisión (Estados Unidos) Chivas vs Pumas: México, por medio del Canal 5 de Televisa, TUDN (Estados Unidos) América vs. León: México, por medio de Fox Sports Premium, TUDN (Estados Unidos) Atlético San Luis vs Monterrey: México, por medio de ESPN, Star+ (Estados Unidos) ¿En qué casas de apuestas puedo apostar en los cuartos de final de la Liga MX 2023? Bet365 1xBet Codere Betway Strendus 10Bet 20Bet Ganabet Leon No te pierdas ni un solo minuto de la acción en los cuartos de final de la Liga MX 2023. Consulta nuestro calendario detallado y únete a la emoción de estos apasionantes partidos. Además, aprovecha las increíbles cuotas de ganancias que ofrecen nuestros sitios de apuestas deportivas. Conéctate con la emoción del fútbol mexicano y eleva la adrenalina con cada jugada. ¡Ingresa ahora y vive la pasión de la Liga MX al máximo! FAQ | Preguntas Frecuentes ¿Cuántos equipos participan en los cuartos de final? Serán 8 equipos los que participarán en los cuartos de final de la Liga MX 2023. ¿Cuándo y dónde se jugará el partido inaugural de los cuartos de final? El partido inaugural se dará entre los equipos América vs León, en el Estadio Guanajuato del Nou Camp, el miércoles 29 de noviembre de 2023; siendo su partido de ida. Y el enfrentamiento de vuelta será el 02 de diciembre de 2023 en el Estadio Azteca. ¿Cuál es el estadio que albergará la final de los cuartos de final de la Liga MX 2023? La final se llevará a cabo en el estadio Olímpico Universitario. ¿Cuál es el equipo favorito para ganar la Liga MX según las casas de apuestas? Según las casas de apuestas, el equipo favorito con 40 puntos se encuentra el América con cuotas altas y competitivas en las diferentes casas de apuestas. Contact Details Acroud Media info-media@acroudmedia.com

November 29, 2023 09:43 AM Eastern Standard Time

Image
Article thumbnail News Release

Pending $400 Million Purchase Agreement To Advance Sharps Into Large Prefillable Syringe Market With Differentiated Copolymer Syringe Systems

Benzinga

By Meg Flippin, Benzinga Sharps Technology Inc. (NASDAQ: STSS) is an innovative medical device and pharmaceutical packaging company that seems positioned for growth through its commercial-ready, patented copolymer syringe products. The company recently announced a pending asset purchase agreement to acquire the InjectEZ specialty copolymer syringe manufacturing facility and a 10-Year purchase agreement for over $400 million from Nephron Pharmaceuticals, a privately held healthcare company. Sharps Technology has a stated mission to be a leader in the copolymer prefillable syringe system segment as the pharmaceutical industry shifts toward using these applications. The market opportunity that Sharps has identified, through target customers in the large-cap pharmaceutical and specialty biotech segments of the market, represents a significant opportunity for the company with opportunities for growth and profitability. The company says its advanced syringe offerings are easy to use and have built-in features to protect a person from needle stick injuries, blood-borne infections like hepatitis B and C and HIV. Vaccinations, medicine delivery and newly approved drug administration via the biotech industry are leading applications for Sharps’ syringes, and it’s a market growing at a CAGR of 11.95% from 2022 to 2030. Sharps’ Differentiated Products Are Stronger Than Glass When it comes to prefilled syringes, not all of them are created equal. Glass syringes have been the de facto standard but they have deficiencies that need to be overcome whether in a hospital setting or at home. For starters, glass syringes are prone to breakage as compared to Sharps’ COC (cyclic olefin copolymer) based prefilled syringes. Sharps’ copolymer products address many of the other historic deficiencies that glass-based syringes experience in the field. At present, COC syringes are comparable to glass in terms of barrier quality, long term drug stability and imperviousness to oxygen and water vapor contamination. They can exceed glass syringes in breakage rates, drug shelf life, cold chain storage, and cost to manufacture. Sharps’ product pipeline and market strategy will include a broad range of sizes, silicon free systems that address contamination issues for the healthcare market, dual chamber systems that improve drug shelf life while reducing unnecessary packaging and customized solutions for systems that serve the growing autoinjector segment. To further the market, Sharps recently inked a deal with Nephron Pharmaceuticals Corp. to make these advanced syringe systems. Nephron is a leader in contract manufacturing of generic medications and 503B outsourcing that includes extensive use of prefillable sterile syringes. Under the terms of the deal, Sharps will acquire Nephron’s InjectEZ specialty syringe manufacturing facility for $50 million. This includes a 10-year purchase agreement for over $400 million from Nephron Pharmaceuticals for Sharps’ next-generation copolymer prefillable syringe systems. Understanding The Prefillable Syringe Market The prefillable syringe market is a sub-industry within the healthcare sector that is growing faster than GDP at a 4x multiple of GDP. The U.S. market has seen growth over the past few years, driven by reducing hospital errors and administration injuries, increased use of biologics and biosimilars that require administration by injection, and need for more efficient drug delivery systems. Injectables were 37% of the global drug delivery market in 2017 and increased to 44% by 2021, even before COVID vaccines further increased syringe demand. Prefillable syringe capacity is at a premium, due to the global lack of capacity, increasing demand and technical challenges in production. Specifically, prefillable COC syringe demand growth is outstripping industry capacity. Additionally, these products are increasingly being used in the delivery of biologic drugs, biosimilars and in the development of new formulations of existing drugs. Larger molecules are becoming more complex and require exceptional delivery mechanisms. Copolymer Prefillable Syringes: A Niche Market That Seems To Be Taking Off The prefilled syringe market has growth prospects within the healthcare sector and Sharps will serve both Nephron and other pharmaceutical and healthcare customers within the copolymer segment of the market. With a lack of available capacity for these products and the technical challenges in producing them, Sharps says that it is at an advantage in the marketplace. The company has assembled a management team with a wealth of experience in developing copolymer syringes, which many rivals can’t claim. That’s evident with its Nexent line of syringes made of advanced polymer material for improved long-term drug stability and preserved efficacy. The material is also break-resistant and includes a robust container closure system utilizing common, industry standard rubber formulations, making it easier to pass regulatory scrutiny. Sharps sees a big market opportunity with its copolymer prefillable syringes including biologics and cold chain vaccines, serving potential customers in Japan, Europe, and North America, three regions with increasing demand through their rapidly aging populations. “With this landmark purchase agreement in place for our copolymer prefillable syringes, we will accelerate the realization of our shared goals, transition the company to revenue, and propel Sharps into a new phase of growth and sustainability,” commented Robert Hayes, Sharps CEO. “At the forefront of our growth trajectory are our copolymer-based prefillable syringe systems, a sector that is experiencing escalating market demand and is poised to shape the future of Sharps Technology.” To review the corporate website, CLICK HERE. To review the investors section for the website, CLICK HERE. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

November 29, 2023 09:25 AM Eastern Standard Time

1 ... 577578579580581 ... 3725